Retraction: An MSN-PEG-IP drug delivery system and IL13Rα2 as targeted therapy for glioma

Jinlong Shi1, Shiqiang Hou1, Jianfei Huang2

  • 1Jiangsu Clinical Medicine Centre of Tissue Engineering and Nerve Injury Repair, Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong 226001, China. ntshiwei123@163.com.

Nanoscale
|February 7, 2024
PubMed

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...